v3.22.4
Condensed Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Current assets:      
Cash and cash equivalents $ 5,781,918 $ 40,750,133 $ 13,953,513
Marketable securities 20,752,290    
Accounts receivable 13,842 110,141 0
Prepaid research and development 932,419 107,000 774,356
Prepaid expenses and other current assets 505,924 1,502,725 54,837
Total current assets 27,986,393 42,469,999  
Equipment and improvements 241,574    
Right-of-use asset 353,250    
Total assets 28,581,217 42,469,999 14,782,706
Current liabilities:      
Accounts payable 781,223 1,089,778 1,720,680
Lease obligation, current 142,048    
Accrued expenses and other current liabilities 2,289,726 2,715,761 632,934
Deferred revenue   0 2,325,741
Notes payable 0 248,911 42,534
Total current liabilities 3,212,997 4,054,450 4,721,889
Notes payable, net of current portion   0 276,461
Lease obligations 232,020    
Total liabilities 3,445,017 4,054,450 4,998,350
Commitments and contingencies (see Note 15)  
Stockholders' equity:      
Preferred stock 0 0 0
Common stock 25,227 25,155 10,051
Additional paid-in capital 68,676,935 68,208,081 24,805,929
Accumulated other comprehensive income 26,828 0  
Accumulated deficit (43,592,790) (29,817,687) (15,031,624)
Total stockholders' equity 25,136,200 38,415,549 9,784,356
Total liabilities and stockholders' equity $ 28,581,217 $ 42,469,999 $ 14,782,706